Qiagen adds Horizon QC, 7/16
July 2016—Qiagen announced that it will offer an extensive package of quality control data, generated through the application of Horizon Discovery Group’s reference standards, with its GeneReader NGS System.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
July 2016—Qiagen announced that it will offer an extensive package of quality control data, generated through the application of Horizon Discovery Group’s reference standards, with its GeneReader NGS System.
July 2016—Aushon BioSystems has launched the Ciraplex Ultra Ultrasensitive Assays with femtogram/milliliter level detection to address multiple biomarkers in a wide range of therapeutic areas.
July 2016—Mawi DNA Technologies announced that Omega Bio-tek has successfully developed an automated DNA purification method from iSwab-DNA with its Mag-Bind Blood and Tissue DNA HDQ chemistry on the Hamilton MicroLabStar automation platform.
July 2016—The Cyto-ID Autophagy Detection Kit 2.0 from Enzo Life Sciences measures autophagic vacuoles and monitors autophagic flux in lysosomally inhibited live cells using a novel dye that selectively labels accumulated autophagic vacuoles.
July 2016—Sysmex and Siemens Healthineers Laboratory Diagnostics announced an extension to their partnership through at least 2020.
July 2016—Foundation Medicine has launched an analytically validated and accurate blood-based circulating tumor DNA assay that provides patients and oncologists with a new option for comprehensive genomic profiling when a tissue biopsy is not feasible or when tissue is not available.
June 2016—SeraCare Life Sciences launched its AccuPlex Zika Reference Material aimed to provide a safe, nonreplicative, and fully extractable positive material that covers the entire Zika virus genome.
June 2016—Presto from Milestone Medical is a fully automated benchtop processor/stainer for high-quality frozen sections.
June 2016—In a joint effort to provide customers with an advanced solution for molecular testing, Siemens and Thermo Fisher Scientific announced a strategic relationship that includes the integration of Thermo Fisher Scientific’s real-time PCR system into Siemens’ Versant kPCR Molecular Solution.
June 2016—Rheonix, in collaboration with New York University College of Dentistry, has received funding from a Small Business Innovation Research Phase I/II Fast-track grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health to develop a rapid diagnostic for Zika virus infection.